Pioneering cell therapies for non-responders to current immunotherapies

New research signposts a new, less invasive approach to identify killer T lymphocytes in patients with gastrointestinal tumors with low mutational burden who are refractory to approved immune-based treatments.

From http://besthealthnews.com/2019/10/pioneering-cell-therapies-for-non-responders-to-current-immunotherapies/?utm_source=rss&utm_medium=rss&utm_campaign=pioneering-cell-therapies-for-non-responders-to-current-immunotherapies

from
https://healthnews010.wordpress.com/2019/10/17/pioneering-cell-therapies-for-non-responders-to-current-immunotherapies/

From https://jamesjohnson10.blogspot.com/2019/10/pioneering-cell-therapies-for-non.html

from
https://jamesjohnson10.wordpress.com/2019/10/17/pioneering-cell-therapies-for-non-responders-to-current-immunotherapies/